92 algorithm-development-"Multiple"-"Prof"-"St"-"Simons-Foundation" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
visit here . As a successful candidate you will: · Focus on metabolic regulations of cardiovascular disease under cancer treatment and metabolic syndrome · Utilize multiple cutting-edge
-
characters in Japanese. Include the research concept you wish to pursue.) If there is another main laboratory you wish to belong to, indicate that name and prepare a statement of reasons separately. Please
-
Southwestern (UTSW) Medical Center in Dallas, seeks applications for multiple postdoctoral fellow positions to investigate memory mechanisms in the mammalian brain using innovative molecular, cellular
-
and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical
-
-cell development and lymphoid leukemogenesis and the application of these mechanistic insights to the development of novel anti-cancer immunotherapy approaches, methods to improve T-cell recovery
-
clear data presentation, ability to work efficiently in a team and with collaborators Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage Previous
-
for Pulmonary and Vascular Biology at UT Southwestern Medical Center (Dallas TX, USA) is seeking two self-motivated postdoctoral fellows to join the team to lead multiple NIH-funded projects. The Shaul-Mineo Lab
-
the laboratory of Dr. Qiang Zhu (https://zhulab.vai.org/) at Van Andel Institute (VAI). The research group combines multidisciplinary technologies to study disease mechanisms and develop innovative therapeutic
-
research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals. Responsibilities We invite
-
developing drugs for the treatment of cancer, vascular anomalies, macular degeneration and glaucoma. The group is dedicated to identifying novel targets, pursuing high throughput screening of therapeutics and